Skip to main content
Equibles

TUDOR INVESTMENT CORP ET AL

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 923093 STAMFORD, CT
Back to INO Full portfolio

Position in INO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$68,758 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
14 quarters on record

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Derivatives in INO

reported options exposure · as of Jun 30, 2026
CallValue
$330,000
CallShares
300,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $414,135,114 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 943,287 $66,643,226
2 RPRX
Royalty Pharma plc
 610,736 $34,243,967
3 XENE
Xenon Pharmaceuticals Inc.
 545,387 $32,919,559
4 ABVX
Abivax S.A.
 187,335 $24,964,262
5 INSM
INSMED Inc
 195,391 $20,832,588
6 MLYS
Mineralys Therapeutics, Inc.
 738,370 $19,921,222
7 ABCL
AbCellera Biologics Inc.
 2,063,191 $16,196,049
8 QURE
uniQure N.V.
 328,889 $15,148,627

All Filings in INO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $330,000 300,000
2023-12-31 $68,758 134,820
2023-09-30 $88,148 226,021
2023-06-30 $249,067 553,484
2023-03-31 $110,552 134,820
2022-12-31 $217,459 139,397
2022-06-30 $340,002 196,533
2022-03-31 $178,545 49,734
2021-12-31 $1,616,600 323,968
2021-09-30 $1,960,794 273,854
2021-06-30 $924,413 99,721
2020-09-30 $235,491 20,301
2020-06-30 $476,745 17,690
2020-03-31 $168,977 22,712